Genetic Program
PGT-A (Preimplantation Genetic Testing for Aneuploidies)
PGT-A is an advanced genetic screening technique that revolutionizes the selection of embryos created through IVF. By conducting comprehensive examinations for chromosomal abnormalities, this treatment ensures only the healthiest and most viable embryos are chosen for implantation. PGT-A empowers prospective parents by providing informed decision-making, reducing the risk of miscarriages, and increasing the chances of a successful pregnancy. At Ferty9, state-of-the-art technology is used to deliver accurate and reliable results.
PGT-M (Preimplantation Genetic Testing for Monogenic/Single Gene Disorders)
PGT-M is a transformative solution for couples with hereditary infertility conditions. PGT-M enables meticulous screening of embryos for specific genetic mutations, ensuring only unaffected embryos are prioritized for implantation.
PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements)
PGT-SR, is a remarkable technique tailored for couples with structural chromosomal rearrangements. Through detailed analysis of embryos, doctors can pinpoint genetically balanced embryos, increasing the likelihood of a successful pregnancy. The expert genetic specialists employ cutting-edge methodologies to ensure precision in identifying the healthiest embryos for implantation. With PGT-SR, Ferty9 is advancing fertility treatment and genetic empowerment, guiding you towards a promising future filled with healthy possibilities.
FAQ's
What is genetic testing?
Genetic testing is a medical diagnostic procedure that examines a person's genes, chromosomes, or proteins to identify any changes or mutations that may be present. These tests help determine the risk of developing certain genetic conditions or assess the likelihood of passing on these conditions to future generations. Genetic testing plays a critical role in reproductive medicine, helping individuals and couples make informed choices about their fertility issues and family planning options.
What is PGT
Preimplantation Genetic Testing (PGT) is a specialised type of genetic testing conducted on embryos created through in vitro fertilisation (IVF). PGT includes analysing a small number of cells from the embryo to identify genetic abnormalities or mutations. This advanced technology allows fertility specialists to select the healthiest embryos for transfer, increasing the possibilities of a successful pregnancy and lowering the risk of genetic diseases in offspring.
Who should get the genetic testing done
Fertility professionals generally recommend genetic testing for couples who have a known family history of genetic disorders or are carriers of specific genetic mutations. It can also be beneficial for individuals or couples who have a history of recurrent miscarriages, failed IVF attempts, or advanced maternal age. By identifying potential genetic issues before embryo transfer, PGT provides valuable information that helps fertility specialists tailor treatment plans and improve the chances of a successful pregnancy.
What is PGT-A (Preimplantation Genetic Testing for Aneuploidy)
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a specific type of genetic testing that screens embryos for chromosomal abnormalities, such as aneuploidy. Aneuploidy indicates an abnormal number of chromosomes in an embryo, which can result in implantation failure, miscarriages, or the birth of a child with genetic disorders. By recognising embryos with the correct number of chromosomes, PGT-A enables embryologists to select the most viable embryos for transplantation, increasing the chances of a successful pregnancy.
What is PGT-M (Preimplantation Genetic Testing for Monogenic Disorders)?
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) is a specialised method to help identify specific gene mutations or single gene disorders in embryos. Healthcare professionals recommend this type of testing for couples who are potential carriers of genetic disorders, such as autosomal recessive, autosomal dominant, and X-linked disorders. PGT-M allows embryologists to select embryos that are free from these genetic disorders, reducing the possibility of passing them on to future generations. It provides hope for couples who have a high risk of having a child with a severe genetic condition.
What is PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements)?
Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) is a specialised genetic testing technique that helps detect structural abnormalities in embryos. Structural rearrangements refer to changes in the structure of chromosomes, such as translocations or inversions, which can result in implantation failure, miscarriage, or the birth of a child with genetic disorders. PGT-SR allows embryologists to identify embryos with these structural rearrangements and select those with a higher possibility of successful implantation and a lower risk of genetic disorders.
